您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > 4,5,6,7-Tetrabromobenzimidazole
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
4,5,6,7-Tetrabromobenzimidazole
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
4,5,6,7-Tetrabromobenzimidazole图片
CAS NO:577779-57-8
包装与价格:
包装价格(元)
25mg电议
250mg电议

产品介绍
4,5,6,7-Tetrabromobenzimidazole 是一种选择性和 ATP 竞争性 CK2(酪蛋白激酶 2)抑制剂。
Cas No.577779-57-8
别名4,5,6,7-四溴苯并咪唑,Casein Kinase II Inhibitor XII,TBBz
化学名4,5,6,7-tetrabromo-1H-benzimidazole
Canonical SMILESBrC1=C2C(N=CN2)=C(Br)C(Br)=C1Br
分子式C7H2Br4N2
分子量433.7
溶解度DMSO: Soluble,Ethanol: Soluble
储存条件Store at -20℃
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping ConditionEvaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
产品描述

Ki: 0.5-1 μM

4,5,6,7-Tetrabromobenzimidazole is a CK2 inhibitor.

Casein kinase 2 (CK2), a constitutive protein kinase involved in many signal transduction pathways, is known to be able to negatively regulate apoptosis, and its activity is increased in various proliferating tissues and tumors.

In vitro: Previous study found that like the reported 4,5,6,7-tetrabromobenzotriazole (TBBt), the structurally related 4,5,6,7-tetrabromobenzimidazole (TBBz) was a selective ATP-competitive inhibitor of protein kinase CK2 from various sources including yeast, rat liver, Neurospora crassa and Candida tropicalis, with K(i) values in the range 0.5-1 μM. TBBz was found to virtually inactive vs. PKA, PKC, and a very weak inhibitor of protein kinase CK1. TBBt was noted to be a more effective inhibitor of PK60S than of yeast CK2; by contrast, TBBz was a relatively feeble inhibitor of PK60S, thus more selective than TBBt vs. CK2 in yeast cells. Therefore, similar to TBBt, TBBz could be regarded as an additional lead compound for development of more potent inhibitors of CK2 [1].

In vivo: Up to now, therer is no animal in vivo data reported.

Clinical trial: So far, no clinical study has been conducted.

Reference:
[1] Zien, P. ,Bretner, M.,Zastapilo, K., et al. Selectivity of 4,5,6,7-tetrabromobenzimidazole as an ATP-competitive potent inhibitor of protein kinase CK2 from various sources. Biochemical and Biophysical Research Communications 306(1), 129-133 (2003).